The position of mefloquine as a 21st century malaria chemoprophylaxis
Open Access
- 9 December 2010
- journal article
- review article
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 357
- https://doi.org/10.1186/1475-2875-9-357
Abstract
Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria. Travellers to high-risk Plasmodium falciparum endemic areas need an effective chemoprophylaxis.Keywords
This publication has 67 references indexed in Scilit:
- Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-AfricaBMC Infectious Diseases, 2010
- Sex and Gender Differences in Travel‐Associated DiseaseClinical Infectious Diseases, 2010
- Multicenter EuroTravNet/GeoSentinel Study of Travel-related Infectious Diseases in EuropeEmerging Infectious Diseases, 2009
- Sex-dependent gene regulatory networks of the heart rhythmFunctional & Integrative Genomics, 2009
- Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian BorneoMalaria Journal, 2009
- Atovaquone‐Proguanil Versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐blind StudyJournal of Travel Medicine, 2007
- Safety of doxycycline and minocycline: A systematic reviewClinical Therapeutics, 2005
- Mefloquine for Malaria Chemoprophylaxis 1992–1998: A ReviewJournal of Travel Medicine, 1999
- Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medicationJournal of Travel Medicine, 1997
- Mefloquine resistance in Plasmodium falciparumParasitology Today, 1995